Drug Combination Details
General Information of the Combination (ID: C82677) | |||||
---|---|---|---|---|---|
Name | Pterostilbene NP Info | + | 3-methyladenine Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Breast cancer
[ICD-11: 2C60]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | VIM | Molecule Info |
Pathway MAP
|
|
In-vitro Model | MDA-MB-231 | CVCL_0062 | Breast adenocarcinoma | Homo sapiens | ||
BT-549 | CVCL_1092 | Invasive breast carcinoma | Homo sapiens | |||
Experimental
Result(s) |
The anti-tumor efficiency of pterostilbene is promoted with a combined treatment of Fas signaling or autophagy inhibitors in triple negative breast cancer cells. |
